✦ LIBER ✦

Use of predictive markers of HIV disease progression in vaccine trials

✍ Scribed by S. Gurunathan; R. El Habib; L. Baglyos; C. Meric; S. Plotkin; B. Dodet; L. Corey; J. Tartaglia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early markers of HIV infection and subcl

✍ M.J. Dolan; D.R. Lucey; C.W. Hendrix; G.P. Melcher; G.A. Spencer; R.N. Boswell 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Immunological and virological markers of

✍ MA Muñoz-Fernández; J. Navarro; E. Obregón; RA Arias; MD Gurbindo; TH Sampelayo; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

Mutation, Fitness, Viral Diversity, and

✍ Castiglione, Filippo; Poccia, Fabrizio; D'Offizi, Gianpiero; Bernaschi, Massimo 📂 Article 📅 2004 🏛 Mary Ann Liebert 🌐 English ⚖ 236 KB

HIV-1-specific functional immune measure

✍ Ronald B. Moss; Steven P. Richieri; François Ferre; Anne E. Daigle; Richard Trau 📂 Article 📅 1997 🏛 BioMed Central 🌐 English ⚖ 802 KB

Barriers of enrolment in HIV vaccine tri

✍ Shayesta Dhalla; Gary Poole 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Orocutaneous manifestations as markers o

✍ YK Sharma; MPS Sawhney; DS Bhakuni; V Gera 📂 Article 📅 2004 🏛 Armed Forces Medical Services, India 🌐 English ⚖ 35 KB